DEANNA OFFENBACK: Open Payments
NPI 1558839142 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 19 payments from 9 companies in 2025. Trend: 2023 $337 · 2024 $523 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $92 |
| Exact Sciences Corporation | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, Cologuard Collection Kit, AIRSUPRA, ZORYVE, SHINGRIX, The Cologuard Plus Collection Kit, GARDASIL 9, OTEZLA.
Industry payments across PA — which companies pay providers there.
